Intermittent antibiotic treatment of bacterial biofilms favors the rapid evolution of resistance
Open Access
- 16 March 2023
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 6 (1) , 1-16
Abstract
Bacterial antibiotic resistance is a global health concern of increasing importance and intensive study. Although biofilms are a common source of infections in clinical settings, little is known about the development of antibiotic resistance within biofilms. Here, we use experimental evolution to compare selection of resistance mutations in planktonic and biofilm Escherichia coli populations exposed to clinically relevant cycles of lethal treatment with the aminoglycoside amikacin. Consistently, mutations in sbmA, encoding an inner membrane peptide transporter, and fusA, encoding the essential elongation factor G, are rapidly selected in biofilms, but not in planktonic cells. This is due to a combination of enhanced mutation rate, increased adhesion capacity and protective biofilm-associated tolerance. These results show that the biofilm environment favors rapid evolution of resistance and provide new insights into the dynamic evolution of antibiotic resistance in biofilms.Keywords
This publication has 108 references indexed in Scilit:
- Bacterial evolution of antibiotic hypersensitivityMolecular Systems Biology, 2013
- From in vitro to in vivo Models of Bacterial Biofilm-Related InfectionsPathogens, 2013
- The evolution of antibiotic susceptibility and resistance during the formation of Escherichia colibiofilms in the absence of antibioticsBMC Ecology and Evolution, 2013
- Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genesNature Genetics, 2011
- A role for tetrahydrofolates in the metabolism of iron-sulfur clusters in all domains of lifeProceedings of the National Academy of Sciences, 2010
- BLAST+: architecture and applicationsBMC Bioinformatics, 2009
- Endogenous oxidative stress produces diversity and adaptability in biofilm communitiesProceedings of the National Academy of Sciences, 2008
- Addition of Rifampin to Standard Therapy for Treatment of Native Valve Infective Endocarditis Caused byStaphylococcus aureusAntimicrobial Agents and Chemotherapy, 2008
- Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencingProceedings of the National Academy of Sciences, 2007
- Natural conjugative plasmids induce bacterial biofilm developmentNature, 2001